Literature DB >> 1963048

A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus.

P R Kinchington1, P Ling, M Pensiero, A Gershon, J Hay, W T Ruyechan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1963048     DOI： 10.1007/978-1-4684-5853-4_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  10 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells.

Authors:  Johnathan Storlie; Wallen Jackson; Jennifer Hutchinson; Charles Grose
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

Authors:  V Traina-Dorge; B Pahar; P Marx; P Kissinger; D Montefiori; Y Ou; W L Gray
Journal:  Vaccine       Date:  2010-07-21       Impact factor: 3.641

5.  Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys.

Authors:  Yang Ou; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

6.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

7.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.

Authors:  J F Moffat; L Zerboni; P R Kinchington; C Grose; H Kaneshima; A M Arvin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 9.  Animal models of varicella zoster virus infection.

Authors:  Kristen Haberthur; Ilhem Messaoudi
Journal:  Pathogens       Date:  2013-05-13

10.  Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens.

Authors:  Wayne L Gray
Journal:  Adv Virol       Date:  2013-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.